{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:30:39Z","timestamp":1786552239208,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.abd.2026.501413","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:49:32Z","timestamp":1783093772000},"page":"501413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric psoriasis: from immunogenetics to targeted therapies"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-9188","authenticated-orcid":false,"given":"Adriana Schikiera","family":"Martinelli Salathiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa Nunes","family":"Secamilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Gagheggi","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Yumi Massuda","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Fernandes Eloy","family":"da Costa Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Ferreira","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2026.501413_bib0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.abd.2026.501413_bib0010","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1111\/ijd.13604","article-title":"Prevalence of psoriasis in Brazil - a geographical survey","volume":"56","author":"Romiti","year":"2017","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0015","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ."},{"key":"10.1016\/j.abd.2026.501413_bib0020","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2009.07.029","article-title":"Incidence of Psoriasis in children: a population-based study","volume":"6","author":"Tollefson","year":"2010","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/pde.13382","article-title":"Pediatric Psoriasis: evolving perspectives","volume":"35","author":"Eichenfield","year":"2018","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S0365-05962009000100002","article-title":"Psoriasis in childhood and adolescence","volume":"84","author":"Romiti","year":"2009","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0035","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.10864","article-title":"Management of psoriasis in children (review)","volume":"22","author":"Branisteanu","year":"2021","journal-title":"Exp Ther Med."},{"key":"10.1016\/j.abd.2026.501413_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/genes14081619","article-title":"Genetic and epigenetic mechanisms of Psoriasis","volume":"14","author":"Mateu-Arrom","year":"2023","journal-title":"Genes (Basel)."},{"key":"10.1016\/j.abd.2026.501413_bib0045","series-title":"Imunodermatologia cl\u00ednica","first-page":"34","article-title":"Psor\u00edase e Artrite Psori\u00e1tica","author":"Restrepo","year":"2025"},{"key":"10.1016\/j.abd.2026.501413_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.crimmu.2023.100067","article-title":"Characteristics and sources of tissue-resident memory T cells in psoriasis relapse","volume":"4","author":"Dong","year":"2023","journal-title":"Curr Res Immunol."},{"key":"10.1016\/j.abd.2026.501413_bib0055","article-title":"Comparison of cytokine expression in paediatric and adult psoriatic skin","volume":"25","author":"Kim","year":"2020","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.abd.2026.501413_bib0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaad.2017.05.017","article-title":"Skin-infiltrating, interleukin-22-producing T cells differentiate pediatric psoriasis from adult psoriasis","volume":"77","author":"Cordoro","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512310","article-title":"The genetic susceptibility to Psoriasis and the relationship of linked genes to our treatment options","volume":"24","author":"Patel","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.abd.2026.501413_bib0070","series-title":"In: Consenso brasileiro de psor\u00edase 2024: algoritmo de tratamento da sociedade brasileira de dermatologia","first-page":"9","author":"Gon\u00e7alves","year":"2024"},{"key":"10.1016\/j.abd.2026.501413_bib0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2340\/00015555-3384","article-title":"Psoriasis and genetics","volume":"100","author":"Dand","year":"2020","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.abd.2026.501413_bib0080","first-page":"52","article-title":"GRAPPA treatment recommendations: 2021 update","volume":"49","author":"Coates","year":"2022","journal-title":"J Rheumatol."},{"key":"10.1016\/j.abd.2026.501413_bib0085","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/biomedicines9080940","article-title":"Pediatric Psoriasis: from new insights into pathogenesis to updates on treatment","volume":"9","author":"Kim","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.abd.2026.501413_bib0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/1346-8138.17049","article-title":"Pediatric psoriasis: Understanding pathological conditions and advances in treatment","volume":"51","author":"Morita","year":"2024","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaad.2019.08.049","article-title":"Joint american academy of dermatology-national psoriasis foundation guidelines of care for the management and treatment of psoriasis in pediatric patients","volume":"82","author":"Menter","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.abd.2021.05.011","article-title":"Generalized pustular Psoriasis (von Zumbusch)","volume":"97","author":"Romiti","year":"2022","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/bjd.20689","article-title":"Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case-control diagnostic accuracy study (DIPSOC study)","volume":"186","author":"Burden-Teh","year":"2022","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0110","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.3390\/ijms23105518","article-title":"Overlapping features of Psoriasis and Atopic Dermatitis: from genetics to immunopathogenesis to phenotypes","volume":"23","author":"Tsai","year":"2022","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.abd.2026.501413_bib0115","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-023-08971-3","article-title":"Autoinflammatory keratinization diseases-the concept, pathophysiology, and clinical implications","volume":"65","author":"Blicharz","year":"2023","journal-title":"Clin Rev Allergy Immunol."},{"key":"10.1016\/j.abd.2026.501413_bib0120","series-title":"Guia pr\u00e1tico das doen\u00e7as autoinflamat\u00f3rias","first-page":"117","article-title":"Defici\u00eancia do antagonista natural da interleucina-1 (DIRA)","author":"Mendon\u00e7a","year":"2024"},{"key":"10.1016\/j.abd.2026.501413_bib0125","series-title":"Guia pr\u00e1tico das doen\u00e7as autoinflamat\u00f3rias","first-page":"123","article-title":"Defici\u00eancia do antagonista natural da interleucina-36 (DITRA)","author":"Rivitti-Machado","year":"2024"},{"key":"10.1016\/j.abd.2026.501413_bib0130","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40257-017-0294-9","article-title":"Pediatric Psoriasis","volume":"18","author":"Relvas","year":"2017","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0135","first-page":"229","article-title":"Brazilian-portuguese version of the children\u2019s dermatology life quality index (CDLQI): validity study","volume":"38","author":"Prati","year":"2010","journal-title":"Med Cutan Iber Lat Am."},{"key":"10.1016\/j.abd.2026.501413_bib0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaad.2019.08.026","article-title":"International Psoriasis council board members and councilors. recategorization of psoriasis severity: delphi consensus from the international Psoriasis council","volume":"82","author":"Strober","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0145","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamadermatol.2017.0499","article-title":"Pediatric Psoriasis comorbidity screening guidelines","volume":"153","author":"Osier","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/pde.14208","article-title":"Pediatric Psoriasis and association with cardiovascular and metabolic comorbidities: systematic review and meta-analysis","volume":"37","author":"Phan","year":"2020","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0155","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40257-025-00965-5","article-title":"The burden of pediatric Psoriasis: a systematic review","volume":"26","author":"Yang","year":"2025","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.abd.2023.08.006","article-title":"Cumulative life course impairment in patients with dermatological diseases, with a focus on psoriasis","volume":"99","author":"Romiti","year":"2024","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.abd.2024.09.010","article-title":"Latin American consensus on psoriasis severity classification","volume":"100","author":"Londo\u00f1o-Garc\u00eda","year":"2025","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0170","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s13555-021-00611-y","article-title":"Urea in dermatology: a review of its emollient, moisturizing, keratolytic, skin barrier enhancing and antimicrobial properties","volume":"11","author":"Piquero-Casals","year":"2021","journal-title":"Dermatol Ther (Heidelb)."},{"key":"10.1016\/j.abd.2026.501413_bib0175","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.4103\/idoj.IDOJ_965_20","article-title":"Recommendations for management of childhood psoriasis","volume":"12","author":"Katakam","year":"2021","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.abd.2026.501413_bib0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.31053\/1853.0605.v80.n4.42874","article-title":"Recomendaciones para el tratamiento de la psoriasis en Pediatr\u00eda","volume":"80","author":"Luna","year":"2023","journal-title":"Rev Fac Cien Med Univ Nac Cordoba."},{"key":"10.1016\/j.abd.2026.501413_bib0185","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.abd.2023.10.002","article-title":"Targeted therapy for immune mediated skin diseases. what should a dermatologist know?","volume":"99","author":"L\u00f3pez","year":"2024","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0190","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"4","author":"Sbidian","year":"2021","journal-title":"Cochrane Database Syst"},{"key":"10.1016\/j.abd.2026.501413_bib0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/pde.14870","article-title":"Biologics for pediatric psoriasis: A systematic review and meta-analysis","volume":"39","author":"Sun","year":"2022","journal-title":"Pediatr Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/12034754231222415","article-title":"A practical guide to using biologics in pediatric dermatology","volume":"28","author":"George","year":"2024","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.abd.2026.501413_bib0205","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/bjd\/ljae502","article-title":"Guselkumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients: results of the phase III randomized placebo-controlled PROTOSTAR study","volume":"192","author":"Prajapati","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2026.501413_bib0210","unstructured":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA). Bul\u00e1rio eletr\u00f4nico [Internet]. Bras\u00edlia: ANVISA; [cited 2026 Apr 19]. Available from: https:\/\/consultas.anvisa.gov.br\/#\/bulario\/q\/?numeroRegistro=112363418."},{"key":"10.1016\/j.abd.2026.501413_bib0215","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas da Psor\u00edase","first-page":"79","year":"2020"},{"key":"10.1016\/j.abd.2026.501413_bib0220","first-page":"275","article-title":"Immunobiologicals in dermatology","volume":"3","author":"DLFD","year":"2022","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/1346-8138.16702","article-title":"Biologics in pediatric psoriasis","volume":"50","author":"Wang","year":"2023","journal-title":"J Dermatol."},{"key":"10.1016\/j.abd.2026.501413_bib0230","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/jdv.17002","article-title":"Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial","volume":"4","author":"Bodemer","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2026.501413_bib0235","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/jdv.16915","article-title":"EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 1: Treatment and monitoring recommendations","volume":"34","author":"Nast","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2026.501413_bib0240","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.abd.2023.04.006","article-title":"Unmet needs in the management of psoriasis in Latin America: a systematic review","volume":"99","author":"Schoenardie","year":"2024","journal-title":"An Bras Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:31:38Z","timestamp":1786548698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059626001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0365059626001261"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2026.501413","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric psoriasis: from immunogenetics to targeted therapies","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2026.501413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501413"}}